Andy Barnett is a seasoned executive with extensive experience in the pharmaceutical industry, currently serving as the VP Global Head of Investor Relations at AstraZeneca since 2022. Previously, they held leadership roles at Roche, including General Manager for Hong Kong and Macau, where they were accountable for the pharmaceutical business and managed a large cross-functional team. Andy's career also includes significant positions at AstraZeneca, leading global marketing efforts for immunotherapies and various oncology portfolios. They have a solid educational background with a BSc (Hons) in Biochemistry from McGill University and completed a program in Business Administration at London Business School. Additionally, Andy served as President of the Hong Kong Association of the Pharmaceutical Industry from 2017 to 2018.
This person is not in the org chart
This person is not in any teams
This person is not in any offices